Srinivas N. Pentyala
Direktor/Vorstandsmitglied bei Translational Research Group, Inc.
Aktive Positionen von Srinivas N. Pentyala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The State University of New York | Corporate Officer/Principal | - | - |
| Translational Research Group, Inc. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Srinivas N. Pentyala
Ehemalige bekannte Positionen von Srinivas N. Pentyala
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Stony Brook University | Corporate Officer/Principal | - | - |
Affinimark Technologies, Inc.
 Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Affinimark Technologies, Inc.
Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Health Technology |
| Translational Research Group, Inc. |
- Börse
- Insiders
- Srinivas N. Pentyala
- Erfahrung
